NSEGeneral UpdatesM&A22 Jun 2026
NAVA LIMITED
General Updates
NAVA LIMITED's Board of Directors has approved the amalgamation of its wholly-owned subsidiary, Nava Healthcare Pte. Ltd. (NHPL), with another wholly-owned subsidiary, Nava Global Pte. Ltd. (NGPL), both based in Singapore. This internal reorganization aims to consolidate the Group's investments (excluding commercial agriculture and O&M services) under a single platform, NGPL, to streamline its holding structure. The move is intended to facilitate strategic business restructuring and enable NGPL to pursue future expansion into value-added healthcare services and other growth opportunities in South East Asia. The transaction is subject to regulatory approvals in Singapore and will not alter NAVA Limited's shareholding pattern.
NSEDisclosure under SEBI Takeover Regulations19 Jun 2026
NAVA LIMITED
Disclosure under SEBI Takeover Regulations
NAVA LIMITED announced the submission of a disclosure by D.Ashok, a promoter, to the Exchange. This disclosure was made under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This specific regulation typically requires promoters to report details of any encumbered (e.g., pledged) shares they hold in the company. While the announcement content does not include specific financial figures or the number of shares involved, it signals a change in the promoter's shareholding status. Investors should note this disclosure as it relates to promoter activity and potential financial arrangements.